Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...

研究人员采用了横断面研究设计，通过便利抽样的方法，从湖南省 6 所三甲医院招募了 432 例 COPD 患者。在研究过程中，运用了多种关键技术方法。首先，利用问卷调查收集数据，采用健康信息素养自评问卷（Health Literacy Self-Assessment Questionnaire，HLSQ）评估患者的 ...

New GOLD guidelines recommend using pre-bronchodilator spirometry to rule out COPD and post-bronchodilator measurements to ...

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy of available treatments ...

While exacerbations are more frequent and severe as COPD progresses, patients with COPD may exacerbate for a variety of reasons. For example, pollution, cigarette smoke and upper respiratory tract ...

Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic ...

This was a single-center, prospective study. Patients with COPD were included if their post-bronchodilator forced expiratory volume in 1 s (FEV 1)/forced vital capacity ratio was <0.7 and FEV 1 ...

About Dupixent Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous ...

Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for COPD ...

Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...

Hazard ratios (HR) for COPD were estimated separately for women and men using statistical modelling ... fewer and fewer ...